Effient and Breo ellipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effient (prasugrel hydrochloride) and Breo ellipta (fluticasone furoate; vilanterol trifenatate). Common drug interactions include hot flush among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Effient and Breo ellipta. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.

What is Breo ellipta?

Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 37,362 Breo ellipta users. Check the latest studies of Breo ellipta.



On Jul, 05, 2026

36 people who take Effient and Breo ellipta together, and have interactions are studied.

Effient and Breo ellipta drug interactions.

What are the common drug interactions of Effient and Breo Ellipta, by gender? *:

female:

  1. Hot flush (sudden feelings of heat)
  2. Dysgeusia (disorder of the sense of taste)
  3. Pain
  4. Swollen tongue (swelling of tongue)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Teeth brittle (other half has a defect in the teeth)
  7. Tooth loss
  8. Arthralgia (joint pain)
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Burning sensation

male:

  1. Diarrhoea
  2. Red blood cell count decreased
  3. Ejection fraction decreased (systolic heart failure)
  4. Haemorrhage (bleeding)
  5. Headache (pain in head)
  6. Hypotension (abnormally low blood pressure)
  7. Kidney infection
  8. Muscle spasms (muscle contraction)
  9. Pruritus (severe itching of the skin)
  10. Rash

What are the common drug interactions of Effient and Breo Ellipta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)

50-59:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Chronic kidney disease
  3. Hypotension (abnormally low blood pressure)
  4. Pruritus (severe itching of the skin)
  5. Renal failure (kidney dysfunction)
  6. Renal impairment (severely reduced kidney function)
  7. Scab (a hard coating on the skin formed during the wound healing)
  8. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

  1. Diarrhoea
  2. Dizziness
  3. Burning sensation
  4. Chronic kidney disease
  5. Cranial nerve disorder (impaired functioning of one of the twelve cranial nerves)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Headache (pain in head)
  8. Hot flush (sudden feelings of heat)
  9. Knee arthroplasty
  10. Muscle spasms (muscle contraction)

What are the existing conditions these people have? *

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 19.44%
  2. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 11.11%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.11%
  4. Stress And Anxiety: 3 people, 8.33%
  5. High Blood Cholesterol: 3 people, 8.33%
  6. Acute Myocardial Infarction (acute heart attack): 3 people, 8.33%
  7. Parkinson's Disease: 2 people, 5.56%
  8. Multiple Myeloma (cancer of the plasma cells): 2 people, 5.56%
  9. High Blood Pressure: 2 people, 5.56%
  10. Hemiplegia (paralysis of one side of the body): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Effient and Breo ellipta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effient and Breo ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Breo ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effient and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Breo ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prasugrel hydrochloride and fluticasone furoate; vilanterol trifenatate (the active ingredients of Effient and Breo ellipta, respectively), and Effient and Breo ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: